Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Notes Payables (2016 - 2024)

Historic Notes Payables for Neuroone Medical Technologies (NMTC) over the last 9 years, with Q1 2024 value amounting to $121896.0.

  • Neuroone Medical Technologies' Notes Payables changed N/A to $121896.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $121896.0, marking a year-over-year change of. This contributed to the annual value of $129116.0 for FY2023, which is N/A changed from last year.
  • As of Q1 2024, Neuroone Medical Technologies' Notes Payables stood at $121896.0.
  • Neuroone Medical Technologies' Notes Payables' 5-year high stood at $129116.0 during Q3 2023, with a 5-year trough of $121896.0 in Q1 2024.